Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Non-Current Assets: 2010-2025

Historic Non-Current Assets for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to $383.3 million.

  • Myriad Genetics' Non-Current Assets fell 51.36% to $383.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $383.3 million, marking a year-over-year decrease of 51.36%. This contributed to the annual value of $729.6 million for FY2024, which is 12.40% down from last year.
  • As of Q3 2025, Myriad Genetics' Non-Current Assets stood at $383.3 million, which was down 2.47% from $393.0 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Non-Current Assets peaked at $1.0 billion during Q1 2021, and registered a low of $383.3 million during Q3 2025.
  • Its 3-year average for Non-Current Assets is $740.3 million, with a median of $793.5 million in 2024.
  • Per our database at Business Quant, Myriad Genetics' Non-Current Assets grew by 10.55% in 2022 and then slumped by 51.36% in 2025.
  • Over the past 5 years, Myriad Genetics' Non-Current Assets (Quarterly) stood at $835.9 million in 2021, then climbed by 10.55% to $924.1 million in 2022, then fell by 9.87% to $832.9 million in 2023, then decreased by 12.40% to $729.6 million in 2024, then slumped by 51.36% to $383.3 million in 2025.
  • Its last three reported values are $383.3 million in Q3 2025, $393.0 million for Q2 2025, and $718.9 million during Q1 2025.